Adial Pharmaceuticals Names Matt Davidson President and CEO
Bitget2026/10/28 21:08- Adial Pharmaceuticals appointed former Verrica Pharmaceuticals CEO Matt Davidson president and CEO, effective October 28, 2026.
- Julie Saiki became chief strategy officer; she previously led Stanford's Phase 1b ulcerative colitis study and consulted at McKinsey & Company.
- Celia Economides joined as chief financial officer, having most recently served as CellCentric's chief financial and business officer.
- David Rubenstein became chief scientist; he previously served as Dermavant Sciences' chief scientific officer, leading tapinarof development.
- Ajay Duggal was appointed consulting chief medical officer; he previously led Takeda's general medicine therapeutic area as vice president.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
